argenx

With a background in research, Ana Céspedes brings her passion for forging connections across disciplines to our argenx Board of Directors. Hear more from Ana about how her immunology experience has resonated with argenx’s commitment to innovation. Discover more about our immunology research: https://bit.ly/4dxs08a #TogetherWeDiscover 

Today we’re announcing our first quarter earnings. It’s been an exciting year and in Q1 alone, we’ve seen ongoing advancement of our immunology pipeline and investment in the Immunology Innovation Program (IIP), leading to the nomination of four new pipeline candidates. We’re proud of our colleagues’ dedication to continued innovation and look forward to continuing to deliver on our goal of bringing novel treatments to autoimmune patients worldwide. #TogetherWeDiscover

May is CIDP Awareness Month and argenx is committed to recognizing those affected by this rare disease. Jamilah shares how her symptoms developed and progressed in just four months, leading to her #CIDP diagnosis in 2021.    Learn more about our commitment to the CIDP community: https://bit.ly/3Wm2nRF #TogetherWeDiscover

We are eager to bring the progress shared at American Academy of Neurology AAN 2024 into our work to transform patient lives. Hear from two of our argonauts as they share their highlights, ranging from the data presentations to their conversations with HCPs. Learn more about our patient commitment: https://bit.ly/4a1tXXm #TogetherWeDiscover #AANAM

This April, argonauts came together at the American Academy of Neurology Annual Meeting to present our latest research and innovations in autoimmune disease treatment. Take a look at how Mariel Maling, Director of U.S. HCP Marketing, spent her day at AAN attending our data presentation, engaging with colleagues, and sharing our immunology insights. #TogetherWeDiscover #AANAM

Co-creation is a key component of the work we do to support the rare disease community. argenx CEO Tim Van Hauwermeiren shares how this work advances through our relationships with the brightest minds in disease biology and the patients directly impacted by our treatments.    Learn more about how we deliver immunology solutions to the patient community: https://bit.ly/3W7Pryw   #TogetherWeDiscover

At American Academy of Neurology (AAN), our CIDP Daily Ability Lab allowed attendees to experience CIDP symptoms firsthand. Our argonauts emphasized the value of putting themselves in the shoes of patients, experiencing how the motor and sensory symptoms of CIDP have profound impacts on daily life. Learn more about our immunology pipeline: https://bit.ly/3Q9YlrG   #TogetherWeDiscover #AANAM 

This week at the American Academy of Neurology (AAN) Annual Meeting, argenx shared a breadth of immunology insights, including data from the Phase 3 ADHERE trial.   #TogetherWeDiscover #AANAM 

From showcasing insights in immunology at #AAD2024 and #GCOM2024, to engaging during new hire onboarding, collaboration is at the core of everything our argonauts do. Learn more about career opportunities at argenx: https://bit.ly/3xoageM #TogetherWeDiscover

Through our Immunology Innovation Program (IIP), we combine our antibody engineering expertise with the disease and biology knowledge of our academic and industry collaborators to help develop meaningful advances in disease understanding and treatment. Learn more about our collaborations with academic and industry partners to co-create new potential treatment candidates: https://bit.ly/3xCAGtg #TogetherWeDiscover